We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Read MoreHide Full Article
In the latest close session, Medtronic (MDT - Free Report) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%.
The medical device company's stock has climbed by 3.92% in the past month, exceeding the Medical sector's loss of 0.38% and the S&P 500's gain of 3.42%.
The upcoming earnings release of Medtronic will be of great interest to investors. The company's earnings report is expected on September 1, 2026. On that day, Medtronic is projected to report earnings of $1.39 per share, which would represent year-over-year growth of 10.32%. Our most recent consensus estimate is calling for quarterly revenue of $9.48 billion, up 10.53% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $5.94 per share and a revenue of $38.66 billion, representing changes of +7.41% and +8.96%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Medtronic. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.03% higher within the past month. Medtronic is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, Medtronic is holding a Forward P/E ratio of 14.66. For comparison, its industry has an average Forward P/E of 20.81, which means Medtronic is trading at a discount to the group.
Meanwhile, MDT's PEG ratio is currently 2.34. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Products was holding an average PEG ratio of 2.07 at yesterday's closing price.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 157, positioning it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
In the latest close session, Medtronic (MDT - Free Report) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%.
The medical device company's stock has climbed by 3.92% in the past month, exceeding the Medical sector's loss of 0.38% and the S&P 500's gain of 3.42%.
The upcoming earnings release of Medtronic will be of great interest to investors. The company's earnings report is expected on September 1, 2026. On that day, Medtronic is projected to report earnings of $1.39 per share, which would represent year-over-year growth of 10.32%. Our most recent consensus estimate is calling for quarterly revenue of $9.48 billion, up 10.53% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $5.94 per share and a revenue of $38.66 billion, representing changes of +7.41% and +8.96%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Medtronic. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.03% higher within the past month. Medtronic is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, Medtronic is holding a Forward P/E ratio of 14.66. For comparison, its industry has an average Forward P/E of 20.81, which means Medtronic is trading at a discount to the group.
Meanwhile, MDT's PEG ratio is currently 2.34. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Products was holding an average PEG ratio of 2.07 at yesterday's closing price.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 157, positioning it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.